When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Myovant Sciences: Is The Ultimate Catalyst Coming?
Myovant Sciences Ltd.
Riding strong data, Myovant recently secured FDA approval for relugolix in treating advanced prostate cancer.
Under the brand Orgovyx, Myovant will market the said drug as soon as in January.
The Orgovyx launch is interesting because of patients favoring the oral pill, especially during COVID. Nevertheless, the COVID situation can slow down commercialization efforts.